[go: up one dir, main page]

NO20054100L - Fremgangsmate for fremstilling av syreaddisjonssalter - Google Patents

Fremgangsmate for fremstilling av syreaddisjonssalter

Info

Publication number
NO20054100L
NO20054100L NO20054100A NO20054100A NO20054100L NO 20054100 L NO20054100 L NO 20054100L NO 20054100 A NO20054100 A NO 20054100A NO 20054100 A NO20054100 A NO 20054100A NO 20054100 L NO20054100 L NO 20054100L
Authority
NO
Norway
Prior art keywords
acid addition
basic compound
preparation
addition salts
polyacidic
Prior art date
Application number
NO20054100A
Other languages
English (en)
Other versions
NO20054100D0 (no
NO331272B1 (no
Inventor
Kimiyuki Shibuya
Tadaaki Ohgiya
Takayuki Matsuda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20054100D0 publication Critical patent/NO20054100D0/no
Publication of NO20054100L publication Critical patent/NO20054100L/no
Publication of NO331272B1 publication Critical patent/NO331272B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
NO20054100A 2003-02-28 2005-09-02 Syreaddisjonssalter av polysure basiske forbindelser samt fremgangsmate for fremstilling derav NO331272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (3)

Publication Number Publication Date
NO20054100D0 NO20054100D0 (no) 2005-09-02
NO20054100L true NO20054100L (no) 2005-09-22
NO331272B1 NO331272B1 (no) 2011-11-14

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054100A NO331272B1 (no) 2003-02-28 2005-09-02 Syreaddisjonssalter av polysure basiske forbindelser samt fremgangsmate for fremstilling derav

Country Status (21)

Country Link
US (2) US7750150B2 (no)
EP (1) EP1598346B1 (no)
JP (2) JP4594863B2 (no)
KR (1) KR101106127B1 (no)
CN (2) CN102702171B (no)
AT (1) ATE554083T1 (no)
AU (1) AU2004215523B2 (no)
BR (1) BRPI0407908A (no)
CA (1) CA2516822C (no)
DK (1) DK1598346T3 (no)
EA (1) EA009045B1 (no)
ES (1) ES2384517T3 (no)
IL (1) IL170093A (no)
IS (1) IS7978A (no)
MX (1) MXPA05009129A (no)
MY (1) MY140618A (no)
NO (1) NO331272B1 (no)
NZ (1) NZ541716A (no)
PL (1) PL378292A1 (no)
TW (2) TWI355384B (no)
WO (1) WO2004076441A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
KR20060111898A (ko) 2003-08-29 2006-10-30 교와 가부시키가이샤 지질-풍부-플라크의 안정화 방법 및 파열 예방방법
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
KR101149954B1 (ko) * 2005-08-30 2012-06-01 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물
US8415372B2 (en) 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
WO2008105442A1 (ja) * 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド誘導体
WO2009004792A1 (ja) * 2007-07-02 2009-01-08 Asahi Kasei Pharma Corporation スルホンアミド化合物及びその結晶
EP2220184B1 (en) * 2007-11-30 2019-03-06 Braggone OY Novel siloxane polymer compositions
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
WO2011081118A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用医薬組成物
US20130066075A1 (en) * 2010-05-19 2013-03-14 Kowa Company, Ltd. Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
US9777028B2 (en) * 2015-06-17 2017-10-03 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
JPWO2018092765A1 (ja) * 2016-11-15 2019-10-17 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
ATE285402T1 (de) * 1997-05-26 2005-01-15 Kowa Co Neue zyklische diaminverbindungen und heilmittel das diese enthält
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
WO2004052861A1 (ja) * 2002-12-12 2004-06-24 Kowa Co., Ltd. ヒドロキシアルキル環状ジアミン化合物
TWI324600B (en) * 2003-07-07 2010-05-11 Kowa Co 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
JP2010235635A (ja) 2010-10-21
JPWO2004076441A1 (ja) 2006-06-01
CA2516822C (en) 2012-09-25
ES2384517T3 (es) 2012-07-06
TW200504052A (en) 2005-02-01
CA2516822A1 (en) 2004-09-10
NZ541716A (en) 2007-11-30
AU2004215523B2 (en) 2009-07-16
US8518936B2 (en) 2013-08-27
CN1753886A (zh) 2006-03-29
DK1598346T3 (da) 2012-05-29
EA200501379A1 (ru) 2006-02-24
WO2004076441A1 (ja) 2004-09-10
TWI374136B (en) 2012-10-11
EP1598346B1 (en) 2012-04-18
US20060079688A1 (en) 2006-04-13
EP1598346A1 (en) 2005-11-23
NO20054100D0 (no) 2005-09-02
BRPI0407908A (pt) 2006-02-14
NO331272B1 (no) 2011-11-14
JP5180998B2 (ja) 2013-04-10
MXPA05009129A (es) 2005-10-20
CN1753886B (zh) 2012-07-18
TW201202218A (en) 2012-01-16
EP1598346A4 (en) 2007-08-15
JP4594863B2 (ja) 2010-12-08
IS7978A (is) 2005-08-12
US20100234599A1 (en) 2010-09-16
TWI355384B (en) 2012-01-01
KR20050105218A (ko) 2005-11-03
IL170093A (en) 2012-02-29
ATE554083T1 (de) 2012-05-15
PL378292A1 (pl) 2006-03-20
CN102702171B (zh) 2014-09-10
US7750150B2 (en) 2010-07-06
MY140618A (en) 2009-12-31
CN102702171A (zh) 2012-10-03
AU2004215523A1 (en) 2004-09-10
EA009045B1 (ru) 2007-10-26
KR101106127B1 (ko) 2012-01-20

Similar Documents

Publication Publication Date Title
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
DK1656386T3 (da) Fremgangsmåde til fremstilling af bisphosphonsyreforbindelser
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
PL1781683T3 (pl) Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
IL178771A0 (en) 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
ATE420875T1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3- indolyl)-butylü-1-piperazinyl)-benzofuran-2- carboxamid
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
ATE459617T1 (de) Verfahren zur herstellung von pyridinmethylsulphinylverbindungen
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
CY1111994T1 (el) Νεα μεθοδος για την παρασκευη σουλφονυλπυρρολιων ως αναστολεις hdac
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
EP1582513A4 (en) PROCESS FOR REDUCING DESHALOGENATION
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
ATE424397T1 (de) Verfahren zur herstellung von losartanderivaten durch chlorierung und reduktion der entsprechenden 1h-imidazol-5-carbaldehyde
BRPI0409644A (pt) processo para a preparação de nicotinaldeìdos
TW200700370A (en) Producing method of haloalkylether compounds
FR2869905B1 (fr) Procede de preparation d'ester de l'acide 1,5-diphenylpyrazole carboxylique.
TW200712054A (en) Method for producing 2,3-dihydropyridazine compound
RU2004102604A (ru) Способ кристаллизации азитромицина дигидрата
RU2018123595A (ru) Способ получения хелатообразующего агента
TH60894A (th) วิธีการสำหรับการเตรียมแอสซิทาโลแพรม
TH84983A (no)
TH85269A (no)
DE60108242D1 (de) Herstellung von hydroxyverbindungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees